SILMA Silmaasema OYJ

Silmäasema Oyj: Two new members to Silmäasema’s Management Team

Silmäasema Oyj: Two new members to Silmäasema’s Management Team

Two new members to Silmäasema’s Management Team



Silmäasema Oyj

Stock Exchange Release - Changes board/management/auditors

11 March 2020 at 10:10 a.m. EET



Silmäasema’s Head of Marketing Anne Rantanen and Chief Information Officer Mika Holsti have been appointed as members of Silmäasema’s Management Team.  



”With these changes we want to highlight the importance of Silmäasema brand and marketing and to tie them more closely to company’s strategy work. Silmäasema has also significant information system projects ongoing, effecting all businesses, so it is important that IT point of view has a clear voice in the Management Team,” says Silmäasema’s CEO Teppo Lindén.      



Silmäasema Management Team as of 11 March 2020:

Teppo Lindén, CEO

Jyrki Alamäki, Sales Director

Mika Holsti, CIO

Jari-Pekka Kelhä, CEO, Silmäasema Optiikka Oy

Sirkka-Liisa Kulmala, HR Director

Tapani Kyrki, Business Director

Sari Nordblad, CFO

Ulla Näpänkangas, CEO, Silmäasema Sairaala Oy

Anne Rantanen, Head of Marketing

Roope Sihvola, Chief Medical Officer 



SILMÄASEMA OYJ





For further information, please contact:

CEO Teppo Lindén, tel. 9

Head of Marketing, Anne Rantanen, tel. 1

CIO Mika Holsti, tel. 6

Head of Communications and Investor Relations, Niina Streng, tel. +358 50 322 5195



Silmäasema is a Finnish company, which offers all products and services for optical retail and eye healthcare nationwide. Silmäasema is the largest private eye clinic provider offering eye surgeries and the second largest optical retail chain in Finland. The Silmäasema chain has nearly 150 stores and 13 eye clinics in Finland as well as eight stores in Estonia. The Silmäasema chain employs over 1,000 eye healthcare professionals. The Silmäasema Group’s net sales were EUR 122.9 million in 2018 and adjusted EBITDA was EUR 11.8 million.

EN
11/03/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Silmaasema OYJ

 PRESS RELEASE

Silmäasema Oyj: Coronaria Oy Has Gained Title to All the Shares in Si...

Silmäasema Oyj: Coronaria Oy Has Gained Title to All the Shares in Silmäasema Oyj and the Shares Have Been Delisted from Nasdaq Helsinki Coronaria Oy Has Gained Title to All the Shares in Silmäasema Oyj and the Shares Have Been Delisted from Nasdaq Helsinki Silmäasema Oyj Stock Exchange Release – Tender Offer 5 May 2020 at 4:00 p.m. EEST Coronaria Oy (“Coronaria”) has today placed security approved by the Arbitral Tribunal and thus gained title to all the shares in Silmäasema Oyj (“Silmäasema”) in accordance with Chapter 18, Section 6 of the Finnish Companies Act. After the security has...

 PRESS RELEASE

Silmäasema Oyj: Coronaria Oy on saanut omistusoikeuden Silmäasema Oy...

Silmäasema Oyj: Coronaria Oy on saanut omistusoikeuden Silmäasema Oyj:n kaikkiin osakkeisiin ja osakkeet ovat poistuneet Nasdaq Helsingin pörssilistalta Coronaria Oy on saanut omistusoikeuden Silmäasema Oyj:n kaikkiin osakkeisiin ja osakkeet ovat poistuneet Nasdaq Helsingin pörssilistalta Silmäasema Oyj                    Pörssitiedote – julkinen ostotarjous                                   5.5.2020 klo 16.00 Coronaria Oy (”Coronaria”) on tänään asettanut välimiesoikeuden hyväksymän vakuuden ja näin ollen saanut omistusoikeuden kaikkiin Silmäasema Oyj:n (”Silmäasema”) osakkeisiin osa...

 PRESS RELEASE

Silmäasema Oyj: Arbitral Tribunal Has Confirmed Coronaria Oy's Redemp...

Silmäasema Oyj: Arbitral Tribunal Has Confirmed Coronaria Oy's Redemption Right to Silmäasema Oyj's Shares and Trading in Silmäasema’s Shares Has Been Suspended Arbitral Tribunal Has Confirmed Coronaria Oy's Redemption Right to Silmäasema Oyj's Shares and Trading in Silmäasema’s Shares Has Been Suspended Silmäasema Oyj Stock Exchange Release – Tender Offer 28 April 2020 at 9:50 a.m. EEST The Arbitral Tribunal appointed by the Redemption Committee of the Finland Chamber of Commerce has on 27 April 2020 confirmed that Coronaria Oy (“Coronaria”) has the right to redeem the minority shares ...

 PRESS RELEASE

Silmäasema Oyj: Välimiesoikeus on vahvistanut Coronaria Oy:n lunastu...

Silmäasema Oyj: Välimiesoikeus on vahvistanut Coronaria Oy:n lunastusoikeuden Silmäasema Oyj:n osakkeisiin ja kaupankäynti Silmäaseman osakkeilla on keskeytetty Välimiesoikeus on vahvistanut Coronaria Oy:n lunastusoikeuden Silmäasema Oyj:n osakkeisiin ja kaupankäynti Silmäaseman osakkeilla on keskeytetty Silmäasema Oyj                    Pörssitiedote – julkinen ostotarjous                                   28.4.2020 klo 9.50 Keskuskauppakamarin lunastuslautakunnan nimittämä välimiesoikeus on 27.4.2020 vahvistanut, että Coronaria Oy:llä (”Coronaria”) on oikeus lunastaa Silmäasema Oyj:n...

 PRESS RELEASE

Silmäasema Oyj: Silmäasema Oyj Applies for Delisting of Its Shares f...

Silmäasema Oyj: Silmäasema Oyj Applies for Delisting of Its Shares from Nasdaq Helsinki Silmäasema Oyj Applies for Delisting of Its Shares from Nasdaq Helsinki Silmäasema Oyj Stock Exchange Release – Inside information 16 April 2020 at 4:05 p.m. EET Silmäasema Oyj’s (“Silmäasema”) Board of Directors has decided to apply for the termination of public trading in Silmäasema shares and the delisting of Silmäasema’s shares from the official list of Nasdaq Helsinki Ltd (“Nasdaq Helsinki”). Coronaria Oy (“Coronaria”) owns more than nine tenths (9/10) of all the shares and votes in Silmäasema a...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch